|
ZNF551 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.581200E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.750400E-01 |
| Normal-vs-Stage2 |
1.990000E-01 |
| Normal-vs-Stage3 |
2.12690000001015E-06 |
| Normal-vs-Stage4 |
2.93389999961313E-07 |
| Stage1-vs-Stage2 |
1.531220E-01 |
| Stage1-vs-Stage3 |
5.17509999964361E-07 |
| Stage1-vs-Stage4 |
4.53469999994738E-07 |
| Stage2-vs-Stage3 |
8.834500E-02 |
| Stage2-vs-Stage4 |
1.449530E-02 |
| Stage3-vs-Stage4 |
2.844000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.735700E-03 |
| Normal-vs-AfricanAmerican |
1.955570E-01 |
| Normal-vs-Asian |
9.403600E-01 |
| Caucasian-vs-AfricanAmerican |
9.088200E-01 |
| Caucasian-vs-Asian |
4.637800E-01 |
| AfricanAmerican-vs-Asian |
5.666600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.163100E-03 |
| Normal-vs-Female |
1.456650E-01 |
| Male-vs-Female |
1.552380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.701600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.048800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.650000E-04 |
| Normal-vs-Age(81-100Yrs) |
2.502100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.662000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.197040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.136400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.298000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.988100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.512970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.838700E-03 |
| Normal-vs-Grade 2 |
7.802800E-01 |
| Normal-vs-Grade 3 |
1.64220999999687E-05 |
| Normal-vs-Grade 4 |
3.55979999921985E-08 |
| Grade 1-vs-Grade 2 |
8.059800E-02 |
| Grade 1-vs-Grade 3 |
1.177170E-04 |
| Grade 1-vs-Grade 4 |
2.09220000002563E-06 |
| Grade 2-vs-Grade 3 |
2.15510000001196E-06 |
| Grade 2-vs-Grade 4 |
9.604100004168E-08 |
| Grade 3-vs-Grade 4 |
1.501940E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.453200E-01 |
| Normal-vs-ccB subtype |
3.504600E-03 |
| ccA subtype-vs-ccB subtype |
1.980770E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.469680E-02 |
| Normal-vs-N1 |
9.190000E-02 |
| N0-vs-N1 |
3.363200E-01 |
|
|
